Atlas Trials

Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)

Clinical trial NCT01097044 · COMPLETED

Trial details

NCT number
NCT01097044
Sponsor
Clinuvel Pharmaceuticals Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Erythropoietic Protoporphyria
Start date
2010-04-01
Primary completion
2011-04-01
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.